Navigation Links
Study finds women slightly more likely to die than men in the 30 days following a heart attack
Date:8/25/2009

A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS. The study, published in the August 26, 2009 issue of the Journal of the American Medical Association (JAMA), found however that overall there was no significant difference in mortality observed between the sexes after a heart attack. The large observational study pooled 136,247 ACS patients from 11 independent, international randomized clinical trials between 1993 and 2006.

Cardiovascular disease is the number one killer of men and women. The major cause of death from cardiovascular disease is acute coronary syndromes, the dangerous rupture of plaque inside the heart's coronary artery. Three types of ACS, or heart attack, include unstable angina (worsening chest pain or chest pain at rest) that may progress to a heart attack; a less severe heart attack with partial or temporary blockages known as Non-ST segment elevation myocardial infarction (NSTEMI); or a more severe heart attack called ST segment elevation myocardial infarction (STEMI) - caused by complete or a persistently blocked blood supply to the heart.

"Our research concludes that there is a difference in mortality between men and women depending on the type of ACS they suffer," said lead study author, Jeffrey Berger, MD, MS, Director of Cardiovascular Thrombosis, Cardiovascular Clinical Research Center, The Leon H Charney Division of Cardiology at NYU School of Medicine. "Among STEMI or more severe heart attacks - 30 day mortality was significantly higher among women than men. For NSTEMI or less severe heart attacks and unstable angina women had lower 30 day mortality than men. The lower risk in women after a less severe presentation is likely explained by the less severe blockages seen in women. The higher risk of women after a more severe presentation following total coronary occlusion STEMI - may be explained by the reduced collateral blood flow observed in women."

According to study authors, sex is an important factor in the study of ACS and should be considered in future research and delivery of care to men and women who present with ACS. "This study shines a light on ACS in men and women. Studies like this have the ability to improve healthcare for men and women- helping physicians understand sex-differences in why heart attacks happen, and therefore target treatments more effectively and provide for better outcomes," said Dr. Berger.

The study highlights the important sex-differences in the complex spectrum of ACS including how plaque rupture is more common in men, but plaque erosion is more common in women. Women were older at the time of ACS with more comorbidities such as diabetes, hypertension and hypercholesterolemia. Women who underwent catheterization were more likely to have non-obstructive disease and less multi-vessel disease than men. This difference was most pronounced in NSTEMI or unstable angina, where women had a 2 -fold higher prevalence of non-obstructive disease. Women had lower rates of coronary stenosis or narrowing of arteries compared to men.

"Discovering and understanding the health differences among men and women may lead to better diagnostics, risk assessment and better treatment of all patients with ACS and the ability to save more lives," said co-author Judith Hochman, MD, MA, Harold Snyder Family Professor of Cardiology and director of Cardiovascular Clinical Research Center at New York University School of Medicine. " Our study indicates that STEMI, NSTEMI and unstable angina should be evaluated separately. We are actively investigating the mechanism of STEMI and NSTEMI heart attacks in women without coronary blockages."


'/>"/>

Contact: Lauren Woods
lauren.woods@nyumc.org
212-404-3753
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related biology news :

1. Worlds last great forest under threat: New study
2. Study: Smoking may worsen malnutrition in developing nations
3. Research supports calls to study health benefits of nitrate, nitrite
4. Study: Young Arctic muskoxen better at keeping warm than scientists thought
5. No comfort in comfort foods during tough economic times, says Moore School of Business study
6. NSF Emerging Frontiers program supports development of smart materials based on study of fish
7. CSHL study finds short- and long-term memories require same gene but in different circuits
8. Water quality improves after lawn fertilizer ban, study shows
9. Study supports DNA repair-blocker research in cancer therapy
10. K-State lab gives researchers the tools to study porcine circovirus associated diseases
11. New study shows that cocoa flavanols can be preserved during cooking and baking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017  Protagonist Therapeutics, Inc. ... it has initiated a global Phase 2b induction ... peptide that targets alpha4beta7 integrin. The aim of ... to evaluate the safety/tolerability and efficacy of PTG-100 ... moderate to severe active disease. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Attagene , a Research ... U.S. Small Business Administration. The Tibbetts Award honors the Small Business Innovation ... and are considered the best of the best from the thousands of firms ...
(Date:1/13/2017)... -- Research and Markets has announced the addition of ... to 2021" report to their offering. ... The biosimilars market is expected to ... 2016, at a CAGR of 26.3%. The global ... and application. Factors such as rising incidence of various diseases, increasing ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... teamed up with several companies to offer its customers three new solutions for ... probe would come in handy if a customer has an oddly-shaped sample that ...
Breaking Biology Technology: